This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Natural History of Atherosclerosis

This study has been completed.
Districthospital of Bellinzona
Information provided by (Responsible Party):
University of Zurich Identifier:
First received: November 19, 2008
Last updated: December 22, 2011
Last verified: December 2011
20 patients will be recruited. The aim of the study is to determine the natural progression of atherosclerotic disease.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Natural 1-year History of Atherosclerosis in Asymptomatic Patients With Mild to Moderate Carotid Stenosis

Resource links provided by NLM:

Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Progression of atherosclerotic plaque [ Time Frame: 12 months ]

Enrollment: 30
Study Start Date: January 2007
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
asymptomatic patients with mild to moderate carotid artery stenosis


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients of the districthospital Bellinzona

Inclusion Criteria:

  • stable carotid artery disease not requiring revascularization
  • asymptomatic carotid artery stenosis < 80% or symptomatic patients with stenosis < 60 %
  • prophylactic therapy with aspirin (> 100mg/day, statin, blood pressure therapy if indicated (goal < 130/80 mmHg))
  • informed consent

Exclusion Criteria:

  • non atherosclerotic occlusive disease (Bürgers disease)
  • uncontrolled BP (DBP > 110 mmHg and/or SBP > 200 mmHg)
  • hemorrhagic disease or platelet count < 100'000 mm^3
  • Known active liver disease (elevations of GPT GOT or increased ammonia)
  • impaired renal function (crea > 180 mmol/l)
  • pregnancy
  • severe claustrophobic reactions
  • short - term life - threatening pathology
  • physically unable to participate in the study
  • compliance not guaranteed
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00918541

Ospedale San Giovanni Bellinzona
Bellinzona, Switzerland
Ospedale San Giovanni
Bellinzona, Switzerland
Cardiovascular Center Cardiology University Hospital Zürich
Zürich, Switzerland
Sponsors and Collaborators
University of Zurich
Districthospital of Bellinzona
Principal Investigator: Roberto Corti, MD Cardiovascular Center Cardiology, University Hospital Zürich, Zürich Switzerland
Principal Investigator: Augusto Gallino, MD Ospedale San Giovanni Bellinzona, Switzerland
  More Information

Responsible Party: University of Zurich Identifier: NCT00918541     History of Changes
Other Study ID Numbers: CarotidMRI
Study First Received: November 19, 2008
Last Updated: December 22, 2011

Keywords provided by University of Zurich:
atherosclerotic disease
natural progression of atherosclerotic disease
natural history of atherosclerosis at the level of the carotid artery as evaluated by MRI

Additional relevant MeSH terms:
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases processed this record on August 17, 2017